$CBDY
Target Group Inc.

2023 Q3 Form 10-Q Financial Statement

#000141057823001629 Filed on August 09, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2
Revenue $1.046M $759.0K
YoY Change
Cost Of Revenue $454.2K $369.3K
YoY Change
Gross Profit $592.0K $389.7K
YoY Change
Gross Profit Margin 56.58% 51.35%
Selling, General & Admin $380.0K $255.0K
YoY Change 11.55% -3.01%
% of Gross Profit 64.19% 65.43%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $237.8K $229.6K
YoY Change 7.89% 1.88%
% of Gross Profit 40.17% 58.91%
Operating Expenses $648.5K $500.4K
YoY Change 132.84% 74.68%
Operating Profit -$56.50K -$110.7K
YoY Change
Interest Expense $337.7K $369.1K
YoY Change 25.48% 35.51%
% of Operating Profit
Other Income/Expense, Net -$300.3K $1.075M
YoY Change 490.11% 101.19%
Pretax Income -$356.8K $963.8K
YoY Change 24.69% 289.26%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$356.8K $963.8K
YoY Change 24.69% 289.26%
Net Earnings / Revenue -34.1% 126.99%
Basic Earnings Per Share $0.00 $0.00
Diluted Earnings Per Share $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 617.0M 617.0M
Diluted Shares Outstanding 617.0M 727.4M

Balance Sheet

Concept 2023 Q3 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $450.0K $1.048M
YoY Change 127.61% 817.46%
Cash & Equivalents $453.9K $1.057M
Short-Term Investments
Other Short-Term Assets $50.00K $51.36K
YoY Change -91.08% -89.67%
Inventory $1.893M $1.815M
Prepaid Expenses $41.79K $42.67K
Receivables $128.2K $2.068K
Other Receivables $70.00K $4.810K
Total Short-Term Assets $2.585M $2.921M
YoY Change 199.59% 288.65%
LONG-TERM ASSETS
Property, Plant & Equipment $5.428M $5.773M
YoY Change -4.74% -8.13%
Goodwill $263.6K $269.2K
YoY Change -92.26% -92.57%
Intangibles
YoY Change
Long-Term Investments $0.00 $1.024M
YoY Change -100.0% 53.8%
Other Assets
YoY Change
Total Long-Term Assets $5.742M $6.098M
YoY Change -41.05% -42.73%
TOTAL ASSETS
Total Short-Term Assets $2.585M $2.921M
Total Long-Term Assets $5.742M $6.098M
Total Assets $8.327M $9.019M
YoY Change -21.46% -20.88%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $530.0K $507.0K
YoY Change -88.09% -81.13%
Accrued Expenses $2.270M $2.434M
YoY Change 54.88% 96.87%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $990.00
YoY Change -100.0% -98.81%
Long-Term Debt Due $2.126M $1.540M
YoY Change 15.59% -23.24%
Total Short-Term Liabilities $8.411M $8.020M
YoY Change 31.83% 81.59%
LONG-TERM LIABILITIES
Long-Term Debt $5.583M $6.332M
YoY Change -3.17% 4.12%
Other Long-Term Liabilities $1.230M $1.290M
YoY Change -7.64% -10.82%
Total Long-Term Liabilities $6.771M $7.565M
YoY Change -3.34% -20.06%
TOTAL LIABILITIES
Total Short-Term Liabilities $8.411M $8.020M
Total Long-Term Liabilities $6.771M $7.565M
Total Liabilities $15.18M $15.59M
YoY Change 13.42% 12.29%
SHAREHOLDERS EQUITY
Retained Earnings -$30.92M -$30.57M
YoY Change 15.12% 15.01%
Common Stock $61.70K $61.70K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$6.855M -$6.567M
YoY Change
Total Liabilities & Shareholders Equity $8.327M $9.019M
YoY Change -21.46% -20.88%

Cashflow Statement

Concept 2023 Q3 2023 Q2
OPERATING ACTIVITIES
Net Income -$356.8K $963.8K
YoY Change 24.69% 289.26%
Depreciation, Depletion And Amortization $237.8K $229.6K
YoY Change 7.89% 1.88%
Cash From Operating Activities -$570.0K -$122.1K
YoY Change -541.96% -90.94%
INVESTING ACTIVITIES
Capital Expenditures $10.00K
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$10.00K $984.4K
YoY Change -119.94% -25.89%
Cash From Investing Activities -$10.00K $984.4K
YoY Change -119.94% -25.89%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 113.3K
YoY Change -100.0% -299.61%
NET CHANGE
Cash From Operating Activities -570.0K -122.1K
Cash From Investing Activities -10.00K 984.4K
Cash From Financing Activities 0.000 113.3K
Net Change In Cash -580.0K 975.6K
YoY Change -701.1% -1388.77%
FREE CASH FLOW
Cash From Operating Activities -$570.0K -$122.1K
Capital Expenditures $10.00K
Free Cash Flow -$580.0K
YoY Change -549.72%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q4 us-gaap Other Receivable After Allowance For Credit Loss Current Related Party Type Extensible Enumeration
OtherReceivableAfterAllowanceForCreditLossCurrentRelatedPartyTypeExtensibleEnumeration
http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2022Q4 us-gaap Other Receivable After Allowance For Credit Loss Related Party Type Extensible Enumeration
OtherReceivableAfterAllowanceForCreditLossRelatedPartyTypeExtensibleEnumeration
http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2022Q4 us-gaap Accounts Payable Current Related Party Type Extensible Enumeration
AccountsPayableCurrentRelatedPartyTypeExtensibleEnumeration
http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2022Q4 us-gaap Accounts Payable Noncurrent Related Party Type Extensible Enumeration
AccountsPayableNoncurrentRelatedPartyTypeExtensibleEnumeration
http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2022Q2 us-gaap Interest Expense Operating Related Party Type Extensible Enumeration
InterestExpenseOperatingRelatedPartyTypeExtensibleEnumeration
http://fasb.org/us-gaap/2023#RelatedPartyMember
us-gaap Interest Expense Operating Related Party Type Extensible Enumeration
InterestExpenseOperatingRelatedPartyTypeExtensibleEnumeration
http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2023Q2 us-gaap Inventory Net
InventoryNet
1814902
CY2023Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
42674
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
41714
CY2023Q2 us-gaap Value Added Tax Receivable Current
ValueAddedTaxReceivableCurrent
1034
CY2023Q2 us-gaap Interest Expense Operating Related Party Type Extensible Enumeration
InterestExpenseOperatingRelatedPartyTypeExtensibleEnumeration
http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
1000000
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
1000000
dei Entity Central Index Key
EntityCentralIndexKey
0001586554
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Trading Symbol
TradingSymbol
CBDY
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
617025999
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
617025999
CY2023Q2 us-gaap Other Receivable After Allowance For Credit Loss Current Related Party Type Extensible Enumeration
OtherReceivableAfterAllowanceForCreditLossCurrentRelatedPartyTypeExtensibleEnumeration
http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2023Q2 us-gaap Other Receivable After Allowance For Credit Loss Related Party Type Extensible Enumeration
OtherReceivableAfterAllowanceForCreditLossRelatedPartyTypeExtensibleEnumeration
http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2023Q2 us-gaap Accounts Payable Current Related Party Type Extensible Enumeration
AccountsPayableCurrentRelatedPartyTypeExtensibleEnumeration
http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2023Q2 us-gaap Accounts Payable Noncurrent Related Party Type Extensible Enumeration
AccountsPayableNoncurrentRelatedPartyTypeExtensibleEnumeration
http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2023Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
us-gaap Interest Expense Operating Related Party Type Extensible Enumeration
InterestExpenseOperatingRelatedPartyTypeExtensibleEnumeration
http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2022Q2 us-gaap Inventory Net
InventoryNet
0
dei Amendment Flag
AmendmentFlag
false
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-55066
dei Entity Registrant Name
EntityRegistrantName
TARGET GROUP INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
46-3621499
dei Entity Address Address Line1
EntityAddressAddressLine1
20 Hempstead Drive
dei Entity Address Address Line2
EntityAddressAddressLine2
Hamilton
dei Entity Address City Or Town
EntityAddressCityOrTown
Ontario
dei Entity Address Country
EntityAddressCountry
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
L8W 2E7
dei City Area Code
CityAreaCode
1 905
dei Local Phone Number
LocalPhoneNumber
541-3833
dei Security12g Title
Security12gTitle
Common Stock, Par Value $0.0001
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
617025999
CY2023Q2 us-gaap Cash
Cash
1047833
CY2022Q4 us-gaap Cash
Cash
223843
CY2023Q2 us-gaap Restricted Cash
RestrictedCash
8686
CY2022Q4 us-gaap Restricted Cash
RestrictedCash
8490
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2068
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2068
CY2022Q4 cbdy Receivables From Joint Venture Current
ReceivablesFromJointVentureCurrent
630180
CY2023Q2 us-gaap Other Receivables
OtherReceivables
3777
CY2022Q4 us-gaap Other Receivables
OtherReceivables
3692
CY2023Q2 us-gaap Assets Current
AssetsCurrent
2920974
CY2022Q4 us-gaap Assets Current
AssetsCurrent
909987
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5773235
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5554225
CY2022Q4 us-gaap Equity Method Investments
EquityMethodInvestments
775577
CY2023Q2 us-gaap Goodwill
Goodwill
269175
CY2022Q4 us-gaap Goodwill
Goodwill
263117
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
55237
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
62728
CY2023Q2 us-gaap Assets Noncurrent
AssetsNoncurrent
6097647
CY2022Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
6655647
CY2023Q2 us-gaap Assets
Assets
9018621
CY2022Q4 us-gaap Assets
Assets
7565634
CY2023Q2 us-gaap Bank Overdrafts
BankOverdrafts
506
CY2022Q4 us-gaap Bank Overdrafts
BankOverdrafts
506
CY2023Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
2823400
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
2296935
CY2022Q4 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
35254
CY2023Q2 cbdy Related Party Payables Net Current
RelatedPartyPayablesNetCurrent
5061467
CY2022Q4 cbdy Related Party Payables Net Current
RelatedPartyPayablesNetCurrent
4468535
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
118047
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
110586
CY2023Q2 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
480
CY2022Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
480
CY2023Q2 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
16318
CY2022Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
15125
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
8020218
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
6927421
CY2023Q2 us-gaap Accounts Payable Interest Bearing Noncurrent
AccountsPayableInterestBearingNoncurrent
6275163
CY2022Q4 us-gaap Accounts Payable Interest Bearing Noncurrent
AccountsPayableInterestBearingNoncurrent
5877930
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1288897
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1319619
CY2023Q2 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
931
CY2022Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
489
CY2023Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
7564991
CY2022Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
7198038
CY2023Q2 us-gaap Liabilities
Liabilities
15585209
CY2022Q4 us-gaap Liabilities
Liabilities
14125459
CY2023Q2 us-gaap Preferred Stock Value
PreferredStockValue
100
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
100
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
61703
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
61703
CY2023Q2 cbdy Shares To Be Issued Total
SharesToBeIssuedTotal
175293
CY2022Q4 cbdy Shares To Be Issued Total
SharesToBeIssuedTotal
175182
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
24985697
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
24985697
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-30565571
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-30783678
CY2023Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1223810
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-998829
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-6566588
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-6559825
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
9018621
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7565634
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
758984
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
758984
CY2023Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
369261
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
369261
CY2023Q2 us-gaap Gross Profit
GrossProfit
389723
us-gaap Gross Profit
GrossProfit
389723
CY2023Q2 us-gaap Professional Fees
ProfessionalFees
15883
CY2022Q2 us-gaap Professional Fees
ProfessionalFees
7454
us-gaap Professional Fees
ProfessionalFees
16106
us-gaap Professional Fees
ProfessionalFees
18693
CY2023Q2 us-gaap Management Fee Expense
ManagementFeeExpense
77191
CY2022Q2 us-gaap Management Fee Expense
ManagementFeeExpense
55631
us-gaap Management Fee Expense
ManagementFeeExpense
155515
us-gaap Management Fee Expense
ManagementFeeExpense
83516
CY2023Q2 cbdy Salary And Wage Nonofficer
SalaryAndWageNonofficer
53083
CY2022Q2 cbdy Salary And Wage Nonofficer
SalaryAndWageNonofficer
8056
cbdy Salary And Wage Nonofficer
SalaryAndWageNonofficer
53083
cbdy Salary And Wage Nonofficer
SalaryAndWageNonofficer
-9775
CY2023Q2 us-gaap Legal Fees
LegalFees
145987
CY2022Q2 us-gaap Legal Fees
LegalFees
105647
us-gaap Legal Fees
LegalFees
203927
us-gaap Legal Fees
LegalFees
172591
CY2023Q2 us-gaap Depreciation
Depreciation
229568
CY2022Q2 us-gaap Depreciation
Depreciation
225335
us-gaap Depreciation
Depreciation
442254
us-gaap Depreciation
Depreciation
452959
CY2023Q2 cbdy Operating Lease Income Expense
OperatingLeaseIncomeExpense
-28400
CY2022Q2 cbdy Operating Lease Income Expense
OperatingLeaseIncomeExpense
10378
cbdy Operating Lease Income Expense
OperatingLeaseIncomeExpense
-17310
cbdy Operating Lease Income Expense
OperatingLeaseIncomeExpense
33905
CY2023Q2 cbdy General And Administrative Income Expense
GeneralAndAdministrativeIncomeExpense
-56502
CY2022Q2 cbdy General And Administrative Income Expense
GeneralAndAdministrativeIncomeExpense
89143
cbdy General And Administrative Income Expense
GeneralAndAdministrativeIncomeExpense
-59131
cbdy General And Administrative Income Expense
GeneralAndAdministrativeIncomeExpense
68946
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
500448
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
286490
us-gaap Operating Expenses
OperatingExpenses
841160
us-gaap Operating Expenses
OperatingExpenses
634683
CY2023Q2 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-4301
CY2022Q2 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-834
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-1326
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
16812
CY2023Q2 cbdy Gain Loss On Settlement Of Liability
GainLossOnSettlementOfLiability
1428185
cbdy Gain Loss On Settlement Of Liability
GainLossOnSettlementOfLiability
1428185
CY2023Q2 us-gaap Interest Expense
InterestExpense
369092
CY2022Q2 us-gaap Interest Expense
InterestExpense
272373
us-gaap Interest Expense
InterestExpense
722698
us-gaap Interest Expense
InterestExpense
561061
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
727426007
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
773218857
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
727426007
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
773218857
CY2023Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-48519
CY2022Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
76027
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-50794
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
41993
CY2023Q2 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
12507
CY2022Q2 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
637591
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
16782
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
697776
CY2022Q2 cbdy Allowance Recovery For Sales Tax Recoverable
AllowanceRecoveryForSalesTaxRecoverable
1750
cbdy Allowance Recovery For Sales Tax Recoverable
AllowanceRecoveryForSalesTaxRecoverable
2259
CY2023Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
68115
CY2022Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
104923
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
24152
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
151048
CY2023Q2 cbdy Debt Issuance Costs
DebtIssuanceCosts
12354
CY2022Q2 cbdy Debt Issuance Costs
DebtIssuanceCosts
12994
cbdy Debt Issuance Costs
DebtIssuanceCosts
24757
cbdy Debt Issuance Costs
DebtIssuanceCosts
26243
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1074541
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
534090
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
669544
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
322584
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
963816
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
247600
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
218107
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-312099
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
963816
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
247600
us-gaap Net Income Loss
NetIncomeLoss
218107
us-gaap Net Income Loss
NetIncomeLoss
-312099
CY2023Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-222962
CY2022Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-27220
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-224981
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-17345
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
740854
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
220380
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-6874
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-329444
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.0016
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.0004
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.0004
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.0005
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
617025999
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
617025999
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
617025999
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
617025999
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.0010
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.0003
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.0000
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.0004
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-7307490
CY2023Q2 cbdy Shares To Be Issued As Compensation To Intellectual Property Rights Value
SharesToBeIssuedAsCompensationToIntellectualPropertyRightsValue
48
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
963816
CY2023Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-222962
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-6566588
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-2701783
CY2022Q2 cbdy Shares To Be Issued As Compensation To Intellectual Property Rights Value
SharesToBeIssuedAsCompensationToIntellectualPropertyRightsValue
114
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
247600
CY2022Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-27220
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-2481289
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-6559825
cbdy Shares To Be Issued As Compensation To Intellectual Property Rights Value
SharesToBeIssuedAsCompensationToIntellectualPropertyRightsValue
111
us-gaap Net Income Loss
NetIncomeLoss
218107
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-224981
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-6566588
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-2152112
cbdy Shares To Be Issued As Compensation To Intellectual Property Rights Value
SharesToBeIssuedAsCompensationToIntellectualPropertyRightsValue
267
us-gaap Net Income Loss
NetIncomeLoss
-312099
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-17345
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-2481289
us-gaap Profit Loss
ProfitLoss
218107
us-gaap Profit Loss
ProfitLoss
-312099
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-1326
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
16812
cbdy Gain Loss On Settlement Of Liability
GainLossOnSettlementOfLiability
1428185
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
409
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
420
cbdy Allowance For Sales Tax Recoverable
AllowanceForSalesTaxRecoverable
2259
us-gaap Depreciation And Amortization
DepreciationAndAmortization
442254
us-gaap Depreciation And Amortization
DepreciationAndAmortization
452959
us-gaap Operating Lease Expense
OperatingLeaseExpense
119562
us-gaap Operating Lease Expense
OperatingLeaseExpense
134199
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
24152
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
151048
cbdy Debt Issuance Costs
DebtIssuanceCosts
24757
cbdy Debt Issuance Costs
DebtIssuanceCosts
26243
cbdy Increase Decrease In Sales Tax Recoverable
IncreaseDecreaseInSalesTaxRecoverable
-36448
cbdy Increase Decrease In Sales Tax Recoverable
IncreaseDecreaseInSalesTaxRecoverable
-12058
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
534095
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-1150218
cbdy Change In Operating Lease Liability Net
ChangeInOperatingLeaseLiabilityNet
160553
cbdy Change In Operating Lease Liability Net
ChangeInOperatingLeaseLiabilityNet
168507
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-308828
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1199180
cbdy Payments For Proceeds From Property Plant And Equipment
PaymentsForProceedsFromPropertyPlantAndEquipment
-5821
cbdy Payments For Proceeds From Property Plant And Equipment
PaymentsForProceedsFromPropertyPlantAndEquipment
321
us-gaap Proceeds From Divestiture Of Interest In Joint Venture
ProceedsFromDivestitureOfInterestInJointVenture
439640
us-gaap Proceeds From Divestiture Of Interest In Joint Venture
ProceedsFromDivestitureOfInterestInJointVenture
1190277
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
445461
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
1189956
us-gaap Proceeds From Repayments Of Bank Overdrafts
ProceedsFromRepaymentsOfBankOverdrafts
83163
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
667846
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
78660
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
139599
cbdy Payment For Settlement Payable
PaymentForSettlementPayable
10000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
667846
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
12224
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
804479
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
3000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
19707
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-2019
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
232333
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
122151
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1056519
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
123132
us-gaap Noncash Or Part Noncash Acquisition Intangible Assets Acquired1
NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1
114
us-gaap Noncash Or Part Noncash Acquisition Intangible Assets Acquired1
NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1
114
us-gaap Interest Paid Net
InterestPaidNet
2084621
CY2023Q2 us-gaap Area Of Land
AreaOfLand
44000
CY2020 cbdy Class Of Warrant Or Right Warrants Exercised During Period
ClassOfWarrantOrRightWarrantsExercisedDuringPeriod
0
cbdy Warrants Purchase
WarrantsPurchase
7211213
cbdy Settlement Liabilities Current And Noncurrent
SettlementLiabilitiesCurrentAndNoncurrent
0
CY2021 cbdy Settlement Liabilities Current And Noncurrent
SettlementLiabilitiesCurrentAndNoncurrent
10000
CY2023Q2 cbdy Working Capital Deficit
WorkingCapitalDeficit
5099244
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-30565571
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Use of Estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="font-weight:normal;">The preparation of the unaudited condensed consolidated interim financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed consolidated interim financial statements and the reported amounts of revenues and expenses during the reporting periods. Estimates may include those pertaining to accruals. Actual results could differ from those estimates.</span></p>
CY2022Q2 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
0
CY2023Q2 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
0
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
758984
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
0
cbdy Revenue From Investments In Joint Venture
RevenueFromInvestmentsInJointVenture
791285
cbdy Revenue From Investments In Joint Venture
RevenueFromInvestmentsInJointVenture
2109626
CY2023Q2 us-gaap Inventory Net
InventoryNet
1814902
CY2022Q4 us-gaap Value Added Tax Receivable Current
ValueAddedTaxReceivableCurrent
0
CY2023Q2 cbdy Allowance On Value Added Tax Recoverable
AllowanceOnValueAddedTaxRecoverable
0
CY2022Q4 cbdy Allowance On Value Added Tax Recoverable
AllowanceOnValueAddedTaxRecoverable
0
CY2017Q3 us-gaap Area Of Land
AreaOfLand
44000
CY2019Q2 us-gaap Area Of Land
AreaOfLand
44000
CY2023Q2 cbdy Cost Of Property Plant And Equipment Of Joint Venture Consolidated
CostOfPropertyPlantAndEquipmentOfJointVentureConsolidated
723231
CY2023Q2 cbdy Depreciation Of Joint Venture Consolidated
DepreciationOfJointVentureConsolidated
15371
CY2023Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
9117060
CY2023Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3343825
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5773235
CY2020Q2 cbdy Loans To Joint Venture Term Of Debt
LoansToJointVentureTermOfDebt
P5Y
CY2023Q2 cbdy Asset Acquired Fair Value Of Inventory Joint Venture
AssetAcquiredFairValueOfInventoryJointVenture
1690368
CY2023Q2 cbdy Asset Acquired Fair Value Of Fixed Assets Joint Venture
AssetAcquiredFairValueOfFixedAssetsJointVenture
534816
CY2023Q2 cbdy Asset Acquired Fair Value Joint Venture
AssetAcquiredFairValueJointVenture
2225184
CY2023Q2 us-gaap Equity Method Investments
EquityMethodInvestments
1023608
CY2023Q2 cbdy Receivables From Joint Venture Current
ReceivablesFromJointVentureCurrent
706598
CY2023Q2 cbdy Release And Settlement Amount To Come Out Of Joint Venture
ReleaseAndSettlementAmountToComeOutOfJointVenture
776382
CY2023Q2 cbdy Investment In Joint Venture Balance
InvestmentInJointVentureBalance
953824
CY2023Q2 cbdy Gain From Termination Of Joint Venture
GainFromTerminationOfJointVenture
1428185
CY2021 cbdy Class Of Warrant Or Right Warrants Exercised During Period
ClassOfWarrantOrRightWarrantsExercisedDuringPeriod
0
CY2018Q2 cbdy Business Acquisition Equity Interest Issuable Percentage
BusinessAcquisitionEquityInterestIssuablePercentage
0.4627
CY2022 cbdy Class Of Warrant Or Right Warrants Exercised During Period
ClassOfWarrantOrRightWarrantsExercisedDuringPeriod
0
CY2023Q2 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
552583
CY2023Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
3613227
CY2023Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
3706326
CY2023Q2 us-gaap Long Term Debt
LongTermDebt
7872136
CY2023Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
1540099
CY2023Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
6332037
CY2020Q3 cbdy Debt Issuance Costs
DebtIssuanceCosts
251518
CY2023Q2 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
107552
CY2023Q2 us-gaap Deferred Finance Costs Current Net
DeferredFinanceCostsCurrentNet
50679
CY2023Q2 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
56873
CY2023Q2 cbdy Accrued Interest Converted Into Principal
AccruedInterestConvertedIntoPrincipal
679770
CY2023Q2 cbdy Accrued Interest Converted Into Principal
AccruedInterestConvertedIntoPrincipal
900000
CY2023Q2 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
3886380
CY2023Q2 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
2935383
CY2023Q2 us-gaap Line Of Credit
LineOfCredit
3786380
CY2023Q2 us-gaap Line Of Credit
LineOfCredit
2859853
us-gaap Line Of Credit Facility Periodic Payment Interest
LineOfCreditFacilityPeriodicPaymentInterest
494865
us-gaap Line Of Credit Facility Periodic Payment Interest
LineOfCreditFacilityPeriodicPaymentInterest
655190
CY2023Q2 cbdy Line Of Credit Facility Accrued Interest
LineOfCreditFacilityAccruedInterest
941134
CY2023Q2 cbdy Line Of Credit Facility Accrued Interest
LineOfCreditFacilityAccruedInterest
1246042
CY2023Q1 cbdy Advance Paid To Related Party
AdvancePaidToRelatedParty
500000.00
CY2023Q1 cbdy Lender Fees
LenderFees
50000
cbdy Number Of Operating Lease Facilities
NumberOfOperatingLeaseFacilities
2
CY2023Q2 us-gaap Lessee Operating Lease Discount Rate
LesseeOperatingLeaseDiscountRate
0.16
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
165264
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
330107
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
333408
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
336742
CY2023Q2 cbdy Lessee Operating Lease Liability Payments Due After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
1147370
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
2312891
CY2023Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
905947
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
1406944
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
118047
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1288897
CY2022Q2 cbdy Gross Operating Lease Expense
GrossOperatingLeaseExpense
66672
cbdy Gross Operating Lease Expense
GrossOperatingLeaseExpense
119562
cbdy Gross Operating Lease Expense
GrossOperatingLeaseExpense
134199
CY2023Q2 cbdy Gross Operating Leases Rent And Utilities Expenses
GrossOperatingLeasesRentAndUtilitiesExpenses
28400
CY2022Q2 cbdy Gross Operating Leases Rent And Utilities Expenses
GrossOperatingLeasesRentAndUtilitiesExpenses
132169
cbdy Gross Operating Leases Rent And Utilities Expenses
GrossOperatingLeasesRentAndUtilitiesExpenses
-35207
cbdy Gross Operating Leases Rent And Utilities Expenses
GrossOperatingLeasesRentAndUtilitiesExpenses
254382
CY2022Q2 cbdy Recoverable Expenses From Jv Co Related To Rent And Utilities
RecoverableExpensesFromJvCoRelatedToRentAndUtilities
209219
cbdy Recoverable Expenses From Jv Co Related To Rent And Utilities
RecoverableExpensesFromJvCoRelatedToRentAndUtilities
67045
cbdy Recoverable Expenses From Jv Co Related To Rent And Utilities
RecoverableExpensesFromJvCoRelatedToRentAndUtilities
422486
CY2023Q2 cbdy Operating Lease Expenses Total
OperatingLeaseExpensesTotal
28400
CY2022Q2 cbdy Operating Lease Expenses Total
OperatingLeaseExpensesTotal
-10378
cbdy Operating Lease Expenses Total
OperatingLeaseExpensesTotal
17310
cbdy Operating Lease Expenses Total
OperatingLeaseExpensesTotal
-33905
us-gaap Interest Expense Debt
InterestExpenseDebt
9
us-gaap Interest Expense Debt
InterestExpenseDebt
18
CY2022Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
15125
cbdy Effect Of Conversion Of Convertible Notes
EffectOfConversionOfConvertibleNotes
0
cbdy Derivative Liability Changes Due To Issuance
DerivativeLiabilityChangesDueToIssuance
0
cbdy Change In Fair Value Of Derivative Liability
ChangeInFairValueOfDerivativeLiability
1193
CY2023Q2 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
16318
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
1000000
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
1000000
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
850000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
850000000
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
617025999
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
617025999
us-gaap Conversion Of Stock Shares Converted1
ConversionOfStockSharesConverted1
100
cbdy Schedule Of Shares To Be Issued
ScheduleOfSharesToBeIssued
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:29.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:47.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:29.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Shares</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Amount</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:47.7%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Description</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:29.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;width:47.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">80,000 shares of common stock to be issued as compensation to advisers and consultants. These were recorded at fair value of $52,000, based on the market price of the Company’s stock on the date of issue.</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:29.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:47.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:29.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">Services</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 115,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 73,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:47.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">35,000 to be issued as settlement of the amount due for website development services amounting to $247,306. The fair value of the shares on the date of settlement was $21,000, resulting in a gain on settlement amounting to $226,306 during the year ended December 31, 2017.</p></td></tr><tr><td style="vertical-align:bottom;width:29.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">Private placements</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 346,296</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 18,787</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;width:47.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">Consideration for private placements with the fair value based on cash proceeds received. Proper allocation between common stock and additional paid-in capital of the amount received will be completed in the period when the shares are issued.</p></td></tr><tr><td style="vertical-align:bottom;width:29.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">Settlement of loans of CannaKorp</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 930,240</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 80,838</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;width:47.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">Refer to Note 14 for details.</p></td></tr><tr><td style="vertical-align:bottom;width:29.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">Agreement with Serious Seeds</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 218,736</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,668</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;width:47.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">As consideration for intellectual property rights granted by Smit. The fair value is based on the market price of the Company’s stock on the date of issue as per the agreement.</p></td></tr><tr><td style="vertical-align:bottom;width:29.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,610,272</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.77%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 175,293</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:47.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr></table>
us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
115000
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
73000
CY2023Q2 cbdy Share Based Compensation Share Based Payments Forfeiture Rate
ShareBasedCompensationShareBasedPaymentsForfeitureRate
0
CY2023Q1 cbdy Share Based Compensation Share Based Payments Forfeiture Rate
ShareBasedCompensationShareBasedPaymentsForfeitureRate
0
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
0.350
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
0.300
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
3.42
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
3.05
CY2023Q2 cbdy Fair Value Assumptions Term
FairValueAssumptionsTerm
P2Y
CY2023Q1 cbdy Fair Value Assumptions Term
FairValueAssumptionsTerm
P2Y
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2023Q2 cbdy Business Acquisition Fair Value Of Equity Interest Issued Or Issuable
BusinessAcquisitionFairValueOfEquityInterestIssuedOrIssuable
138
CY2023Q1 cbdy Business Acquisition Fair Value Of Equity Interest Issued Or Issuable
BusinessAcquisitionFairValueOfEquityInterestIssuedOrIssuable
160
CY2022Q4 cbdy Share Based Compensation Share Based Payments Forfeiture Rate
ShareBasedCompensationShareBasedPaymentsForfeitureRate
0
CY2022Q3 cbdy Share Based Compensation Share Based Payments Forfeiture Rate
ShareBasedCompensationShareBasedPaymentsForfeitureRate
0
CY2022Q2 cbdy Share Based Compensation Share Based Payments Forfeiture Rate
ShareBasedCompensationShareBasedPaymentsForfeitureRate
0
CY2022Q1 cbdy Share Based Compensation Share Based Payments Forfeiture Rate
ShareBasedCompensationShareBasedPaymentsForfeitureRate
0
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
0.300
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
0.300
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
0.300
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
0.250
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
2.79
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
2.79
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
2.99
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
3.06
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0273
CY2022Q4 cbdy Fair Value Assumptions Term
FairValueAssumptionsTerm
P2Y
CY2022Q3 cbdy Fair Value Assumptions Term
FairValueAssumptionsTerm
P2Y
CY2022Q2 cbdy Fair Value Assumptions Term
FairValueAssumptionsTerm
P2Y
CY2022Q1 cbdy Fair Value Assumptions Term
FairValueAssumptionsTerm
P2Y
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2022Q4 cbdy Business Acquisition Fair Value Of Equity Interest Issued Or Issuable
BusinessAcquisitionFairValueOfEquityInterestIssuedOrIssuable
176
CY2022Q3 cbdy Business Acquisition Fair Value Of Equity Interest Issued Or Issuable
BusinessAcquisitionFairValueOfEquityInterestIssuedOrIssuable
288
CY2022Q2 cbdy Business Acquisition Fair Value Of Equity Interest Issued Or Issuable
BusinessAcquisitionFairValueOfEquityInterestIssuedOrIssuable
306
CY2022Q1 cbdy Business Acquisition Fair Value Of Equity Interest Issued Or Issuable
BusinessAcquisitionFairValueOfEquityInterestIssuedOrIssuable
430
CY2023Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
10400008
CY2022Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
53950001
CY2022Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
489
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Issues
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues
298
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease
144
CY2023Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
931
us-gaap Loss Contingency Damages Sought Value
LossContingencyDamagesSoughtValue
1406977
us-gaap Loss Contingency Damages Sought Value
LossContingencyDamagesSoughtValue
1862805
CY2023Q2 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
11098

Files In Submission

Name View Source Status
0001410578-23-001629-index-headers.html Edgar Link pending
0001410578-23-001629-index.html Edgar Link pending
0001410578-23-001629.txt Edgar Link pending
0001410578-23-001629-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tmb-20230630.xsd Edgar Link pending
tmb-20230630x10q.htm Edgar Link pending
tmb-20230630xex10d34.htm Edgar Link pending
tmb-20230630xex31d1.htm Edgar Link pending
tmb-20230630xex31d2.htm Edgar Link pending
tmb-20230630xex32d1.htm Edgar Link pending
tmb-20230630_def.xml Edgar Link unprocessable
tmb-20230630_lab.xml Edgar Link unprocessable
tmb-20230630_pre.xml Edgar Link unprocessable
tmb-20230630x10q_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable
tmb-20230630_cal.xml Edgar Link unprocessable